Structural differences within negative and depressive syndrome dimensions in schizophrenia, organic brain disease, and major depression: A confirmatory factor analysis of the positive and negative syndrome scale.

نویسندگان

  • Daniel P Eisenberg
  • Dmitry B Aniskin
  • Leonard White
  • Judith A Stein
  • Philip D Harvey
  • Igor I Galynker
چکیده

OBJECTIVE The emerging dimensional approach to classification and treatment of psychiatric disorders calls for better understanding of diagnosis-related variations in psychiatric syndromes and for proper validation of psychometric scales used for the evaluation of those syndromes. This study tested the hypothesis that negative and depressive syndromes as measured by the Positive and Negative Syndrome Scale (PANSS) are consistent across different diagnoses. METHOD We administered the PANSS to subjects with schizophrenia (n = 305), organic brain disease (OBD, n = 66) and major depressive disorder (MDD, n = 75). Confirmatory factor analysis (CFA) was used to establish if the PANSS items for negative symptoms and for depression fit the hypothesized factor structure and if the item factor loadings were similar among the diagnostic groups. RESULTS The negative and depressive symptom subscales fit well according to a variety of fit indexes for all groups individually after some modest model modification. However, multisample modeling procedures indicated that the pattern of factor loadings was significantly different among the groups in most cases. CONCLUSION The results of this study indicate diagnosis-related variations in the negative and depressive syndrome dimensions in schizophrenia, OBD and MDD. These results also validate limited use of the PANSS for evaluation of negative and depressive syndromes in disorders other than schizophrenia. Larger studies are warranted to further evaluate clinical and nosologic significance of diagnostic categories, dimensions and structures of psychiatric syndromes.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Efficacy of Risperidone Augmentation with Ondansetron in the Treatment of Negative and Depressive Symptoms in Schizophrenia: A Randomized Clinical Trial

Background: Given the potential role of the 5-hydroxytryptamine-3 receptor in the pathogenesis of schizophrenia, this study was performed to determine whether ondansetron plus risperidone could reduce the negative and depressive symptoms in patients with treatment-resistant schizophrenia.Methods: In a double-blinded, placebo-controlled, randomized trial (IRCT registration # 201112125280N7), in ...

متن کامل

رابطه افسردگی و علایم مثبت در فاز حاد اختلال اسکیزوفرنیای مزمن، بیمارستان روزبه، 81-1380

Background: The results of studies about relationship between depression and positive signs in schizophrenia are controversial and clarifying the nature of this association may be difficult. The aim of present study is to investigate relationship between depressive symptoms and positive signs, in acute phase of patients with chronic schizophrenia, who have been admitted in Roozbeh Hospital. M...

متن کامل

روابط ساختاری میان ابعاد اختلال‌های اضطرابی و افسردگی DSM-IV و ابعاد الگوی سه‌بخشی

 AbstractObjectives: This project assessed the validity of integrative hierarchical model of anxiety and dep-ression by Brown, Chorpita, and Barlow. Through this appraisal, structural relationships were assess- ed between key features of anxiety and depressive disorders and the dimensions of tripartite model of anxiety and depression.Method: In this project, using the findings collected from 25...

متن کامل

Psychometric Properties of the Persian Version of the COVID-19 Anxiety Syndrome Scale in Iranian College Students

Objectives The COVID-19 anxiety syndrome is characterized by threat monitoring, checking, avoidance, and worry. The COVID-19 anxiety syndrome scale (C-19ASS) is a self-report tool to measure this syndrome. The present study was aims to investigate the psychometric properties of the Persian version of C-19ASS in Iranian college students. Methods This is a correlational study. Participants were ...

متن کامل

Effects of Bromocriptine on Negative Symptoms of Schizophrenia: A Double Blind Clinical Trial

Negative symptoms are still a major obstacle in the recovery of schizophrenic patients. Many attempts to develop novel drugs affecting negative symptoms of schizophrenia have yielded insignificant results. This study evaluates the effects of bromocriptine, a dopamine agonist, on negative symptoms of schizophrenia utilizing a placebo-controlled crossover double-blind clinical trial. Methodology:...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Psychopathology

دوره 42 4  شماره 

صفحات  -

تاریخ انتشار 2009